Recommendations for the use of eliglustat in the treatment of adults with Gaucher disease type 1 in the United States.

Saved in:
Bibliographic Details
Title: Recommendations for the use of eliglustat in the treatment of adults with Gaucher disease type 1 in the United States.
Authors: Balwani, Manisha1 manisha.balwani@mssm.edu, Burrow, Thomas Andrew2 thomas.burrow@cchmc.org, Charrow, Joel3 jcharrow@northwestern.edu, Goker-Alpan, Ozlem4 ogokeralpan@oandoalpan.com, Kaplan, Paige5 kaplan@email.chop.edu, Kishnani, Priya S.6 kishn001@mc.duke.edu, Mistry, Pramod7 pramod.mistry@yale.edu, Ruskin, Jeremy8 jruskin@mgh.harvard.edu, Weinreb, Neal9 boneal@winning.com
Source: Molecular Genetics & Metabolism. Feb2016, Vol. 117 Issue 2, p95-103. 9p.
Database: Academic Search Ultimate
Description
ISSN:10967192
DOI:10.1016/j.ymgme.2015.09.002